Godley LA - Search Results

1

Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.

Artz AS, Wickrema A, Dinner S, Godley LA, Kocherginsky M, Odenike O, Rich ES, Stock W, Ulaszek J, Larson RA, van Besien K. Artz AS, et al. Among authors: godley la. Biol Blood Marrow Transplant. 2008 Nov;14(11):1209-16. doi: 10.1016/j.bbmt.2008.08.004. Biol Blood Marrow Transplant. 2008. PMID: 18940674 Free PMC article.

2

Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).

Lai F, Godley LA, Joslin J, Fernald AA, Liu J, Espinosa R 3rd, Zhao N, Pamintuan L, Till BG, Larson RA, Qian Z, Le Beau MM. Lai F, et al. Among authors: godley la. Genomics. 2001 Jan 15;71(2):235-45. doi: 10.1006/geno.2000.6414. Genomics. 2001. PMID: 11161817

3

Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. Qian Z, et al. Among authors: godley la. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14925-30. doi: 10.1073/pnas.222491799. Epub 2002 Nov 4. Proc Natl Acad Sci U S A. 2002. PMID: 12417757 Free PMC article.

4

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.

van Besien K, Artz A, Smith S, Cao D, Rich S, Godley L, Jones D, Del Cerro P, Bennett D, Casey B, Odenike O, Thirman M, Daugherty C, Wickrema A, Zimmerman T, Larson RA, Stock W. van Besien K, et al. J Clin Oncol. 2005 Aug 20;23(24):5728-38. doi: 10.1200/JCO.2005.15.602. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009946 Clinical Trial.

5

Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.

Kline J, Pollyea DA, Stock W, Artz A, Rich E, Godley L, Zimmerman T, Thompson K, Pursell K, Larson RA, van Besien K. Kline J, et al. Bone Marrow Transplant. 2006 Feb;37(3):307-10. doi: 10.1038/sj.bmt.1705249. Bone Marrow Transplant. 2006. PMID: 16400339 Clinical Trial.

6

Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.

Artz AS, Pollyea DA, Kocherginsky M, Stock W, Rich E, Odenike O, Zimmerman T, Smith S, Godley L, Thirman M, Daugherty C, Extermann M, Larson R, van Besien K. Artz AS, et al. Biol Blood Marrow Transplant. 2006 Sep;12(9):954-64. doi: 10.1016/j.bbmt.2006.05.015. Biol Blood Marrow Transplant. 2006. PMID: 16920562 Free article. Clinical Trial.

7

Successful allogeneic transplantation of patients with suspected prior invasive mold infection.

Hill BT, Kondapalli L, Artz A, Smith S, Rich E, Godley L, Odenike O, Pursell KJ, Larson RA, Stock W, van Besien K. Hill BT, et al. Leuk Lymphoma. 2007 Sep;48(9):1799-805. doi: 10.1080/10428190701534390. Leuk Lymphoma. 2007. PMID: 17786717

8

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.

Pollyea DA, Artz AS, Stock W, Daugherty C, Godley L, Odenike OM, Rich E, Smith SM, Zimmerman T, Zhang Y, Huo D, Larson R, van Besien K. Pollyea DA, et al. Bone Marrow Transplant. 2007 Dec;40(11):1027-32. doi: 10.1038/sj.bmt.1705852. Epub 2007 Sep 10. Bone Marrow Transplant. 2007. PMID: 17846595 Clinical Trial.

9

Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.

Gordon MK, Sher D, Karrison T, Kebriaei P, Chuang K, Zhang Y, McDonnell D, Artz A, Godley L, Odenike O, Rich E, Michaelis L, Thirman MJ, Wickrema A, van Besien K, Larson RA, Stock W. Gordon MK, et al. Leuk Lymphoma. 2008 Mar;49(3):531-7. doi: 10.1080/10428190701799043. Leuk Lymphoma. 2008. PMID: 18297531

10

A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia.

Klisovic RB, Stock W, Cataland S, Klisovic MI, Liu S, Blum W, Green M, Odenike O, Godley L, Burgt JV, Van Laar E, Cullen M, Macleod AR, Besterman JM, Reid GK, Byrd JC, Marcucci G. Klisovic RB, et al. Clin Cancer Res. 2008 Apr 15;14(8):2444-9. doi: 10.1158/1078-0432.CCR-07-1320. Clin Cancer Res. 2008. PMID: 18413836 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters